NCT05971693: An ongoing trial by Biosense Webster, Inc.
This trial is ongoing. It must report results 5 days, 2 hours ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05971693 |
|---|---|
| Title | Safety and Effectiveness Evaluation of the OMNYPULSE Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 12, 2023 |
| Completion date | Dec. 10, 2024 |
| Required reporting date | Dec. 10, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |